MKI67 and thyroid gland carcinoma: The use of Ki-67 marker in thyroid cancer specimens is not recommended in current guidelines, nor is it used routinely in clinical practice.19, 25 However, as discussed, there is evidence that it could have a role as a prognostic marker and maybe should be considered for routine use in PTC as it is in other cancer types.26